Prof. Matthew Campbell is the Chair of Neurovascular Genetics in the Smurfit Institute of Genetics at Trinity College Dublin (TCD). His work focuses on the molecular biology of the blood-brain and blood-retina barriers, exploring how tight-junction modulation can enable therapeutic delivery to neural tissues. With over 23 years of research experience, he has secured major funding including an ERC Consolidator Grant and founded a spin-out company focused on neural barrier therapies.
Gene Therapy for AMD
Age related macular degeneration (AMD) is the leading cause of irreversible central blindness in the world and certain forms such as geographic atrophy (GA) are untreatable. The aim...
Lead: Prof. Matthew Campbell
